Phase 2 N=176 Video-assisted Thoracoscopic Surgery - Exparel Study
Pain, Postoperative
Primary: Number of Subjects With Post-operative Opioid Usage — 42; 58 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=174 MOVE!+UP: Testing a Tailored Weight Management Program for Veterans With PTSD
PTSD · Overweight · Obesity
Primary: Weight (Pounds) Change From Baseline to 6 Months Post-baseline — -7.8; -8.9 pounds — p=0.50
Phase 2 N=45 SLM + Axitinib for Clear Cell RCC
Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC)
Primary: Incidence of Adverse Events (AE) Per CTCAE 4.03 — 3; 5; 7; 20 Participants
Phase 2 N=89 A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
Primary: Percentages of Participants Who Achieved at Least 75 Percent (%) Improvement From Baseline in Psoriasis Area and Severity Index (PASI 75) Score at Week 16 — 4.2; 41.9…
N/A N=109 Improving Diabetes in Emerging Adulthood
Diabetes Mellitus, Type 1
Primary: Hemoglobin A1c — 9.6; 9.8; 8.5; 10.9 Percentage (%) of glycated hemoglobin — p=.219
N/A N=1,274 An Innovative Tailored Intervention for Improving Children's Postoperative Recovery (WebTIPS)
Anxiety · Pain · Postoperative Behavior
Primary: Assess Children's Domains of Behavior Indicating Anxiety [Activity, Emotional Expressivity, State of Arousal, Vocalization and Use of Parents] — 43.5; 42.3 score on a…
Phase 1 N=8 Pharmacokinetics in Oral and Intranasal Formulations of Zolmitriptan.
Healthy
Primary: Effects of Zolmitriptan on Heart Rate (HR). — 64.4; 71.7 lpm
Phase 1 N=83 Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809
Healthy
Primary: Number of Participants With Drug-related Adverse Events (AE) — 3; 1; 2; 1 Participants
N/A N=30 Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study
Attention Deficit Hyperactivity Disorder
Primary: Decision Making Involvement Scale [Parent Seek] - Reported by Child — 2.6; 2.9 Scores on a Scale — p=<0.03
N/A N=400 Improving Care for Women With Urinary Incontinence (EMPOWER)
Urinary Incontinence
Primary: Change in Patients' UI Symptoms as Measured by International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) — 8.4; 9.0; 9.9; 8.9…
N/A N=41 Trial of Blood Flow Restriction Plus Physical Therapy vs. Physical Therapy Alone for Lateral Epicondylitis
Lateral Epicondylitis
Primary: Change in Patient Rated Tennis Elbow Evaluation (PRTEE) — 7.63; 17.27 score on a scale
Phase 2 N=150 SMART Use of Medication for the Treatment of Adolescent Severe Obesity
Adolescent Obesity
Primary: Percent Change in Body Mass Index (BMI) — -9.62; -12.27; -4.53; -2.53 % change in body mass index (BMI)
N/A N=186 Hospital Waterbirth Trial to Measure Maternal and Neonatal Outcomes
Pregnancy Related
Primary: Number of Women Using Intravenous Narcotic Analgesia and Epidural Anesthesia — 26; 26 Participants
Phase 2 N=211 Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population
Borderline Personality Disorder
Primary: Efficacy: Difference in the CGI-S A/A From Baseline to Average of Weeks 8 to 12 — -1.47; -1.31 Scores on a scale — p=0.2266
Phase 2 N=123 A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck
Squamous Cell Carcinoma of Head and Neck
Primary: Percentage of Participants With Confirmed Objective Response, as Determined by the Investigator Using Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST…